BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 20885069)

  • 1. Effects of simvastatin on markers of inflammation, oxidative stress and endothelial cell apoptosis in patients on chronic hemodialysis.
    Kirmizis D; Papagianni A; Dogrammatzi F; Skoura L; Belechri AM; Alexopoulos E; Efstratiadis G; Memmos D
    J Atheroscler Thromb; 2010 Dec; 17(12):1256-65. PubMed ID: 20885069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of vitamin E-coated membrane dialyzer compared to simvastatin in patients on chronic hemodialysis.
    Kirmizis D; Papagianni A; Dogrammatzi F; Belechri AM; Alexopoulos E; Efstratiadis G; Memmos D
    Ren Fail; 2012; 34(9):1135-9. PubMed ID: 22950641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of vitamin E-coated membrane dialyser on markers of oxidative stress and inflammation in patients on chronic haemodialysis.
    Kirmizis D; Papagianni A; Belechri AM; Memmos D
    Nephrol Dial Transplant; 2011 Jul; 26(7):2296-301. PubMed ID: 21127134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-density lipoprotein (LDL)-induced monocyte-endothelial cell adhesion, soluble cell adhesion molecules, and autoantibodies to oxidized-LDL in chronic renal failure patients on dialysis therapy.
    O'Byrne D; Devaraj S; Islam KN; Collazo R; McDonald L; Grundy S; Jialal I
    Metabolism; 2001 Feb; 50(2):207-15. PubMed ID: 11229431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of simvastatin on high-sensitivity C-reactive protein and serum albumin in hemodialysis patients.
    Chang JW; Yang WS; Min WK; Lee SK; Park JS; Kim SB
    Am J Kidney Dis; 2002 Jun; 39(6):1213-7. PubMed ID: 12046033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid-lowering therapy corrects endothelial cell dysfunction in a short time but does not affect hypercoagulable state even after long-term use in hyperlipidemic patients.
    Kario K; Matsuo T; Hoshide S; Kobayashi H; Sakata T; Mizuno O; Mitsuhashi T; Ikeda U; Miyata T; Shimada K
    Blood Coagul Fibrinolysis; 1999 Jul; 10(5):269-76. PubMed ID: 10456618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of atorvastatin, simvastatin, and fenofibrate therapy on monocyte chemoattractant protein-1 secretion in patients with hyperlipidemia.
    Kowalski J; Okopień B; Madej A; Zieliński M; Belowski D; Kalina Z; Herman ZS
    Eur J Clin Pharmacol; 2003 Jul; 59(3):189-93. PubMed ID: 12756509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How does short-term low-dose simvastatin influence serum prohepcidin levels in patients with end-stage renal disease? A pilot study.
    Li XY; Chang JP; Su ZW; Li JH; Peng BS; Zhu SL; Cai AJ; Zhang J; Jiang Y
    Ther Apher Dial; 2010 Jun; 14(3):308-14. PubMed ID: 20609184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo and in vitro effects of simvastatin on inflammatory markers in pre-dialysis patients.
    Panichi V; Paoletti S; Mantuano E; Manca-Rizza G; Filippi C; Santi S; Taccola D; Donadio C; Tramonti G; Innocenti M; Casto G; Consani C; Sbragia G; Franzoni F; Galetta F; Panicucci E; Barsotti G
    Nephrol Dial Transplant; 2006 Feb; 21(2):337-44. PubMed ID: 16249194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress improvement is associated with increased levels of taurine in CKD patients undergoing lipid-lowering therapy.
    Zinellu A; Sotgia S; Loriga G; Deiana L; Satta AE; Carru C
    Amino Acids; 2012 Oct; 43(4):1499-507. PubMed ID: 22278741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial dysfunction and low-grade inflammation in the transition to renal replacement therapy.
    Gennip ACEV; Broers NJH; Meulen KJT; Canaud B; Christiaans MHL; Cornelis T; Gelens MACJ; Hermans MMH; Konings CJAM; Net JBV; Sande FMV; Schalkwijk CG; Stifft F; Wirtz JJJM; Kooman JP; Martens RJH
    PLoS One; 2019; 14(9):e0222547. PubMed ID: 31518378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of atorvastatin on lipid profile and non-traditional cardiovascular risk factors in diabetic patients on hemodialysis.
    Navarro JF; Mora C; Muros M; García-Idoate G
    Nephron Clin Pract; 2003; 95(4):c128-35. PubMed ID: 14694274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simvastatin decreases endothelial progenitor cell apoptosis in the kidney of hypertensive hypercholesterolemic pigs.
    Lavi R; Zhu XY; Chade AR; Lin J; Lerman A; Lerman LO
    Arterioscler Thromb Vasc Biol; 2010 May; 30(5):976-83. PubMed ID: 20203299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in the inflammatory and oxidative stress markers during a single hemodialysis session in patients with chronic kidney disease.
    Sangeetha Lakshmi B; Harini Devi N; Suchitra MM; Srinivasa Rao PVLN; Siva Kumar V
    Ren Fail; 2018 Nov; 40(1):534-540. PubMed ID: 30277113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute effect of simvastatin on inflammation and oxidative stress in chronic kidney disease.
    Dummer CD; Thome' FS; Zingano B; Lindoso A; Veronese FV
    J Nephrol; 2008; 21(6):900-8. PubMed ID: 19034875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of fenofibrate and simvastatin on plasma sICAM-1 and MCP-1 concentrations in patients with hyperlipoproteinemia.
    Kowalski J; Okopien B; Madej A; Zielinski M; Belowski D; Kalina Z; Herman ZS
    Int J Clin Pharmacol Ther; 2003 Jun; 41(6):241-7. PubMed ID: 12816176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated serum levels of soluble adhesion molecules predict death in pre-dialysis patients: association with malnutrition, inflammation, and cardiovascular disease.
    Stenvinkel P; Lindholm B; Heimbürger M; Heimbürger O
    Nephrol Dial Transplant; 2000 Oct; 15(10):1624-30. PubMed ID: 11007832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodialysis induces p66(shc) gene expression in nondiabetic humans: correlations with oxidative stress and systemic inflammation.
    Zanetti M; Barazzoni R; Gortan Cappellari G; Burekovic I; Bosutti A; Stocca A; Bianco F; Ianche M; Panzetta G; Guarnieri G
    J Ren Nutr; 2011 Sep; 21(5):401-9. PubMed ID: 21439852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of combining simvastatin with rosiglitazone on inflammation, oxidant stress and ambulatory blood pressure in patients with the metabolic syndrome: the SIROCO study.
    Lazich I; Sarafidis P; de Guzman E; Patel A; Oliva R; Bakris G
    Diabetes Obes Metab; 2012 Feb; 14(2):181-6. PubMed ID: 21955403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of flaxseed oil on serum systemic and vascular inflammation markers and oxidative stress in hemodialysis patients: a randomized controlled trial.
    Mirfatahi M; Tabibi H; Nasrollahi A; Hedayati M; Taghizadeh M
    Int Urol Nephrol; 2016 Aug; 48(8):1335-1341. PubMed ID: 27115157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.